Inhibitory effect of annexin I on synovial inflammation in rat adjuvant arthritis

Arthritis and Rheumatism

Volumn 42, Issue 7, 1999, Pages 1538-1544

  Yang, Yuanhang ^a   Hutchinson, Paul ^a   Morand, Eric F ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; LIPOCORTIN 1; NITRIC OXIDE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG MECHANISM; FLOW CYTOMETRY; MALE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS;

ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS, EXPERIMENTAL; DINOPROSTONE; GLUCOCORTICOIDS; LEUKOCYTES; MALE; NITRIC OXIDE; RATS; RATS, SPRAGUE-DAWLEY; SYNOVIAL MEMBRANE; SYNOVITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033497248     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199907)42:7<1538::AID-ANR29>3.0.CO;2-3     Document Type: Article

References (48)

1. Sternberg EM, Chrousos GP, Wilder RL, Gold PW. The stress response and the regulation of inflammatory disease. Ann Intern Med 1992;117:854-66.
2. Munck A, Guyre PM, Holbrook NJ. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Rev 1984;5:25-44.
3. Wilder RL, Sternberg EM. Neuroendocrine hormonal features in rheumatoid arthritis and related conditions. Curr Opin Rheumatol 1990;2:436-40.
4. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995;332:1351-62.
5. Morand EF, Goulding NJ. Glucocorticoids in rheumatoid arthritis -mediators and mechanisms. Br J Rheumatol 1993;32:816-9.
6. Goulding NJ, Guyre PM. Regulation of inflammation by lipocortin 1. Immunol Today 1992;13:295-7.
7. Flower RJ, Rothwell NJ. Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 1994;15:71-6.
8. Morand EF, Hutchinson P, Hargreaves A, Goulding NJ, Boyce NW, Holdsworth SR. Detection of intracellular lipocortin 1 in human leukocyte subsets. Clin Immunol Immunopathol 1995;76: 195-202.
9. Goulding NJ, Dixey J, Morand EF, Dodds RA, Wilkinson LS, Pitsillides AA, et al. Differential distribution of annexins-I, -II, -IV, and -VI in synovium. Ann Rheum Dis 1995;54:841-5.
10. Santos LL, Morand EF, Hutchinson P, Boyce NW, Holdsworth SR. Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol 1997;107:248-53.
11. Pepinsky RB, Sinclair LK, Douglas I, Liang C-M, Lawton P, Browning JL. Monoclonal antibodies to lipocortin-1 as probes for biological function. FEBS Lett 1990;261:247-52.
12. Perretti M, Flower RJ. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J Immunol 1993; 150:992-9.
13. Yang YH, Hutchinson P, Santos LL, Morand EF. Glucocorticoid inhibition of adjuvant arthritis synovial macrophage nitric oxide production - role of lipocortin 1. Clin Exp Immunol 1998;111:117-22.
14. Hall V, Janick-Buckner D, Eichelberger L. Evaluation of whole blood lysing techniques for animal blood samples [abstract]. Cytometry 1990;4:107.
15. Yang YH, Hutchinson P, Littlejohn GO, Boyce N. Flow cytometric detection of anti-neutrophil cytoplasmic autoantibodies. J Immunol Methods 1994;172:77-84.
16. Vishwanath BS, Frey FJ, Escher G, Reichen J, Frey BM. Liver cirrhosis induces renal and liver phospholipase A2 activity in rats. J Clin Invest 1996;98:365-71.
17. Cirino G, Cicala C, Sorrentino L, Ciliberto G, Arpaia G, Perretti M, et al. Anti-inflammatory actions of an N-terminal peptide from human lipocortin I. Br J Pharmacol 1993;108:573-4.
18. Duncan GS, Peers SH, Carey F, Forder R, Flower RJ. The local anti-inflammatory action of dexamethasone in the rat carrageenin oedema model is reversed by an antiserum to lipocortin 1. Br J Pharmacol 1993;108:62-5.
19. Carey F, Forder R, Edge MD, Greene AR, Horan MA, Strijbos PJLM, et al. Lipocortin-1 fragment modifies the pyrogenic actions of cytokines in rats. Am J Physiol 1990;259:R266-9.
20. Davidson J, Flower RJ, Milton AS, Peers SH, Rotondo D. Antipyretic actions of human recombinant lipocortin-1. Br J Pharmacol 1991;102:7-9.
21. Perretti M, Ahluwalia A, Harris JG, Goulding NJ, Flower RJ. Lipocortin-1 fragments inhibit neutrophil accumulation and neutrophil-dependent edema in the mouse: a qualitative comparison with an anti-CD11b monoclonal antibody. J Immunol 1993; 151:4306-14.
22. Violette SM, King I, Browning JL, Pepinsky RB, Wallner BP, Sartorelli AC. Role of lipocortin I in the glucocorticoid induction of the terminal differentiation of a human squamous carcinoma. J Cell Physiol 1990;142:70-7.
23. Croxtall J, Flower R, Perretti M. The role of lipocortin 1 in the regulation of A549 cell proliferation and leukocyte migration. J Lipid Mediat Cell Signal 1993;6:295-302.
24. Kim KM, Kim DK, Park YM, Kim CK, Na DS. Annexin-I inhibits phospholipase A2 by specific interaction, not by substrate depletion. FEBS Lett 1994;343:251-5.
25. Newman SP, Flower RJ, Croxtall JD. Dexamethasone suppression of IL-1β induced cyclooxygenase 2 expression is not mediated by lipocortin 1 in A549 cells. Biochem Biophys Res Commun 1994; 202:931-9.
26. - generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J Clin Invest 1989;83:1936-40.
27. Wu CC, Croxtall JD, Perretti M, Bryant CE, Thiemermann C, Flower RJ, et al. Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc Natl Acad Sci U S A 1995;92:3473-7.
28. Laue L, Kawai S, Brandon DD, Brightwell D, Barnes K, Knazek RA, et al. Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist. J Steroid Biochem 1988;29:591-8.
29. Flower RJ, Parente L, Persico P, Salmon JA. A comparison of the acute inflammatory response in adrenalectomised and sham-operated rats. Br J Pharmacol 1986;87:57-62.
30. Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, et al. Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis susceptible Lewis rats. Proc Natl Acad Sci U S A 1989;86:2374-8.
31. Vishwanath BS, Frey FI, Bradbury M, Dallman MF, Frey BM. Adrenalectomy decreases lipocortin-1 messenger ribonucleic acid and tissue protein content in rats. Endocrinology 1992;130:585-91.
32. Peers SH, Smillie F, Elderfield AJ, Flower RJ. Glucocorticoid-and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo. Br J Pharmacol 1993;108:66-72.
33. Yang YH, Hutchinson P, Leech M, Morand EF. Exacerbation of adjuvant arthritis by adrenalectomy is associated with reduced leukocyte lipocortin 1. J Rheumatol 1997;24:1758-64.
34. Yang YH, Leech M, Hutchinson P, Holdsworth SR, Morand EF. Anti-inflammatory effect of lipocortin 1 in experimental arthritis. Inflammation 1997;21:583-96.
35. Sudlow AW, Carey F, Forder R, Rothwell NJ. The role of lipocortin 1 in dexamethasone-induced suppression of PGE2 and TNFa release from human peripheral blood mononuclear cells. Br J Pharmacol 1996;117:1449-56.
36. Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993;45 Suppl 1:S3-7.
37. Mancuso F, Flower RJ, Perretti M. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. J Immunol 1995;155:377-86.
38. Leech M, Hutchinson P, Holdsworth SR, Morand EF. Endogenous glucocorticoids influence neutrophil migration and P selectin expression in experimental arthritis. Clin Exp Immunol 1998;112:383-8.
39. Loxley HD, Cowell A-M, Flower RJ, Buckingham JC. Effects of lipocortin 1 and dexamethasone on the secretion of corticotrophin-releasing factors in the rat: in vitro and in vivo studies. J Neuroendocrinol 1993;5:51-61.
40. Taylor AD, Cowell A-M, Flower J, Buckingham JC. Lipocortin 1 mediates an early inhibitory action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro. Neuroendocrinology 1993;58:430-9.
41. Taylor AD, Loxley HD, Flower RJ, Buckingham JC. Immunoneutralization of lipocortin 1 reversed the acute inhibitory effects of dexamethasone on the hypothalamo-pituitary-adrenocortical responses to cytokines in the rat in vitro and in vivo. Neuroendocrinology 1995;62:19-31.
42. Buckingham JC, Loxley HD, Christian HC, Philip JG. Activation of the HPA axis by immune insults: roles and interactions of cytokines, eicosanoids, glucocorticoids. Pharmacol Biochem Behav 1996;54:285-98.
43. Taylor AD, Christian HC, Morris JF, Flower RJ, Buckingham JC. An antisense oligodeoxynucleotide to lipocortin 1 reverses the inhibitory actions of dexamethasone on the release of adrenocorticotropin from rat pituitary tissue in vitro. Endocrinology 1997;138:2909-18.
44. Smith T, Flower RJ, Buckingham JC. Lipocortins I, II and IV in the brain and pituitary gland: selective induction by dexamethasone of lipocortin I in the anterior pituitary gland. Mol Neuropharmacol 1993;3:45-55.
45. Goulding NJ, Godolphin JL, Sharland PR, Peers SH, Sampson M, Maddison PJ, et al. Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone. Lancet 1990;335:1416-8.
46. Perretti M, Flower RJ, Goulding NJ. The ability of murine leukocytes to bind lipocortin 1 is lost during acute inflammation. Biochem Biophys Res Commun 1993;192:345-50.
47. Perretti M, Croxtall JD, Wheller SK, Goulding NJ, Hannon R, Flower RJ. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat Med 1996;2:1259-62.
48. Podgorski MR, Goulding NJ, Hall ND, Flower RJ, Maddison PJ. Autoantibodies to lipocortin 1 are associated with impaired corticosteroid responsiveness in rheumatoid arthritis. J Rheumatol 1992; 19:1668-71.